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The effect of prebiotic fortified 
infant formulas on microbiota 
composition and dynamics in early 
life
Klaudyna Borewicz1, Maria Suarez-Diez  2, Christine Hechler3, Roseriet Beijers3,4, 
Carolina de Weerth4, Ilja Arts  5,6, John Penders7,8, Carel Thijs5, Arjen Nauta9, 
Cordula Lindner9, Ellen Van Leusen9, Elaine E. Vaughan10 & Hauke Smidt  1
Gastrointestinal (GI) microbiota composition differs between breastfed and formula-fed infants. Today’s 
infant formulas are often fortified with prebiotics to better mimic properties of human milk with respect 
to its effect on GI microbiota composition and function. We used Illumina HiSeq sequencing of PCR-
amplified 16S rRNA gene fragments to investigate the composition of faecal microbiota in 2–12 week 
old infants receiving either breastmilk, infant formulas fortified with prebiotics, or mixed feeding. We 
compared these results with results from infants fed traditional formulas used in the Netherlands in 
2002–2003, which contained no added prebiotics. We showed that today’s formulas supplemented with 
either scGOS (0.24–0.50 g/100 ml) or scGOS and lcFOS (at a 9:1 ratio; total 0.6 g/100 ml) had a strong 
bifidogenic effect as compared to traditional formulas, and they also resulted in altered patterns of 
microbial colonisation within the developing infant gastrointestinal tract. We identified three microbial 
states (or developmental stages) in the first 12 weeks of life, with a gradual transition pattern towards 
a bifidobacteria dominated state. In infants receiving only fortified formulas, this transition towards 
the bifidobacteria dominated state was accelerated, whereas in infants receiving mixed feeding the 
transition was delayed, as compared to exclusively breastfed infants.
Microbial colonisation of an infant’s gastrointestinal (GI) tract starts before or at birth and progresses in a 
step-wise fashion during the postnatal period1–3. Many environmental factors may affect GI microbiota com-
position and its development during early life4–8. These early life exposures and associated GI microbiota per-
turbations have been linked with changes in immune development leading to potentially serious and lifelong 
health effects. For example, earlier studies suggested that infants fed formula were at higher risk of nutritional 
deficiencies, asthma, atopy, obesity, developing metabolic syndrome, coeliac disease, diabetes and other diseases, 
as compared to breastfed infants9. Some of the early life exposures cannot be avoided, however, the use of formula 
feeding is, at least in some cases, a choice made by the parents9. Over the last century, when formula feeding 
became more popular worldwide10, intensive research led to developing infant formulas that are increasingly sim-
ilar to human milk with regard to nutrient composition and function. However, they are certainly not identical, 
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and breastmilk with its complex composition still remains the golden standard for infant nutrition10,11. Human 
milk contains a wide range of compounds that modulate the infant intestinal microbiota9,12. One of the prevalent 
and important groups of components are the human milk oligosaccharides (HMOs) that have unique nutritional 
and functional properties13. The prebiotic function of breastmilk as source of growth factors for the “bifidus flora” 
was identified more than a hundred years ago14. Various studies since then confirmed that the GI microbiota of 
breastfed infants is dominated by bifidobacteria, as compared to formula fed infants, a fact which has been most 
often attributed to the presence of HMOs in the human milk, and their lack in infant formulas15,16. Taking into 
account both the wide use of infant formulas and the growing evidence for the importance of GI microbiota 
for health throughout life, it became clear that the functional prebiotic properties of infant formulas needed to 
be addressed. Thus, formulas nowadays are often fortified with prebiotics. In European countries these preb-
iotics include mostly short chain galacto-oligosaccharides (scGOS) alone, or in a mixture with a chicory root 
derived inulin containing long chain fructo-oligosaccharides (lcFOS)17,18. Prebiotics mimic the bifidogenic effect 
of HMOs in human milk and have been associated with improved immunity, bowel function and other health 
benefiting effects in infants13,19,20. However, the exact effect of these functional alternatives on the GI tract micro-
bial ecosystem, most importantly with respect to the dynamics of bacterial colonisation in early life, are not yet 
well understood and should be investigated.
Here we present the results of a longitudinal study in which we compared the colonisation patterns of breast-
fed and formula fed infants, including a group of mixed fed infants. We assessed the microbiota composition in 
faecal samples from two, six and 12 weeks old infants born between years 2015–2016 and receiving commercial 
formulas fortified with GOS and/or FOS. We compared those results with the faecal microbiota composition of 
one month old infants born in 2002–2003 and fed commercial infant formulas purchased during those years. In 
both studies, infants received formulas that were available on the Dutch market at the time the samples were col-
lected. We show that the new prebiotic supplemented formulas have a bifidogenic effect on infant GI microbiota, 
however, they also result in altered dynamics of bacterial colonisation during the first 12 weeks of life as compared 
to breastfed infants.
Results
A total of 443 samples were included in the analyses: 204 samples (from 74 infants) and 239 samples (from 239 
infants) from the BINGO and KOALA cohort, respectively. A total of 28,955,759 sequencing reads were obtained 
from the BINGO cohort samples, with per sample counts ranging from 5,215 to 721,990 (Mean = 141,940; 
SD = 126,570), with 95% of samples having at least 20,000 reads. Sequencing of the KOALA cohort samples 
resulted in a total of 30,132,625 sequencing reads ranging from 1,380 to 448,285 per sample (Mean = 126,078, 
SD = 84,356), with 95% of samples having at least 25,000 reads. Taxonomic classification of OTUs was done 
for the complete sample set using the NG-Tax pipeline against a customised SILVA database21, and it resulted 
in detection of five different phyla, namely Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria, and 
Verrucomicrobia. At the genus level, the most abundant taxa were Bifidobacterium, Bacteroides, Streptococcus, 
Escherichia-Shigella, and an unassigned genus within the family Enterobacteriaceae (Table S1).
Being overall the most abundant genus-level taxonomic group in infant faecal microbiota, we first assessed 
potential differences in relative abundance of bifidobacteria with age and different feeding modes. In the 
BINGO cohort faecal samples were collected between years 2015–2016 from infants at two, six and 12 weeks 
of age, and most commercial infant formulas used in the BINGO cohort contained prebiotics. In the BINGO 
cohort we observed an age related increase in the average relative abundance of bifidobacteria in the BF infants 
(Kruskal-Wallis; p = 0.01). In contrast, in FF and MF infants from the BINGO cohort the relative abundance of 
bifidobacteria fluctuated, and the differences were not significant between different age groups (Kruskal-Wallis: 
p > 0.05). In the BINGO cohort, MF was associated with lower relative abundance of bifidobacteria, as com-
pared to FF infants (Kruskal-Wallis: p = 0.0078). In the KOALA cohort, in which infants were born between 
years 2002–2003, most commercial formulas did not contain added prebiotics. In this cohort, MF resulted in 
significant reduction in the relative abundance of bifidobacteria as compared to BF (Kruskal-Wallis: FDR = 0.05, 
p = 0.00078), but not in comparison to the FF group (Kruskal-Wallis: p > 0.05).
To better relate the results from the two study cohorts we focused our comparisons on the BINGO study 
infants at six weeks of age. FF infants in the BINGO cohort received prebiotic fortified formulas and showed 
higher average relative abundance of bifidobacteria as compared to BF infants (62% in FF vs. 46% in BF.; differ-
ence not statistically significant), whereas in the KOALA cohort the abundance of bifidobacteria in the FF infants 
was significantly lower (Wilcoxon test, FDR < 0.05) than that in the corresponding BF infants from the KOALA 
study (17% in FF vs. 32% in BF) (Fig. 1). In addition, OTU level analyses revealed that in both study cohorts the 
same three Bifidobacterium OTUs (denoted as L1, L2 and B1) were most predominant in the faeces of the one 
month old infants (Fig. S1, Table S2). Remarkably, while in the KOALA cohort formula feeding and breastfeeding 
resulted in significantly different distributions in all three major bifidobacterial OTUs, in the BINGO cohort 
the relative abundance of the most abundant Bifidobacterium OTU L2 was not significantly different between 
infants fed breastmilk, formula or both. In contrast, Bifidobacterium OTU L1 increased significantly in formula 
fed infants in both cohorts. When infants received mixed feeding (breastmilk and formula), there were no sig-
nificant differences in the main bifidobacterial OTUs as compared to breastfed infants in the BINGO cohort, 
whereas in the KOALA cohort there was a significant decrease in the relative abundance of Bifidobacterium OTU 
L2 (Fig. S1).
To identify genus level taxa that were significantly different between BF and FF infants in each study cohort 
(Fig. 1) we used the Wilcoxon test. In the BINGO cohort 12 genus level groups differed significantly between 
BF and FF infants when all age groups were analysed together (FDR < 0.05, p < 0.0057; Fig. 1), but at six weeks 
of age only Blautia (an adult-like taxon) was identified as significantly enriched in the FF group (FDR = 0.0001, 
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p < 0.001). In infants included in the KOALA cohort, the relative abundances of 19 genus level taxa were statisti-
cally different between both feeding types (FDR < 0.05, p < 0.0058; Fig. 1).
Formula feeding significantly (FDR < 0.05) increased relative abundance of Akkermansia, Enterococcus, 
Peptostreptococcaceae Incertae Sedis, and Erysipelotrichaceae Incertae Sedis, and significantly decreased rel-
ative abundance of Staphylococcus and Haemophilus, as compared to the corresponding BF groups in both 
study cohorts. In addition, in the BINGO cohort only, formula feeding significantly increased relative abun-
dance of Blautia, Dorea, Granulicatella, Eubacterium, Catenibacterium, and decreased relative abundance of 
Parabacteroides as compared to the BF group. In the KOALA cohort, formula feeding significantly increased 
relative abundance of Barnesiella, Alistipes, Escherichia-Shigella, Veillonella, Flavonifractor, Clostridium, 
Lachnospiraceae Incertae Sedis, and unidentified genera within the families Ruminococcaceae and 
Enterobacteriaceae, whereas it decreased Bifidobacterium, Lactobacillus, Halomonas, and Aeribacillus as com-
pared to the BF group.
Alpha diversity estimates were compared between feeding modes and between different age groups of infants 
from the BINGO cohort (Fig. 2). There were no statistically significant differences in PD Whole Tree, Shannon 
Diversity Index or Chao1 Index between age groups. No differences between BINGO BF, FF, MF at individual 
time points or when three time points were combined were detected in PD Whole Tree estimates (p = 0.227) 
(data not shown). Shannon Diversity Index values in the BINGO cohort were significantly higher in MF infants 
as compared to BF infants (Shannon Diversity: p = 0.016; Fig. 2e) at week 12 only, or when all age groups were 
combined (Shannon Diversity; p = 0.0035; Fig. 2g). When Chao1 species richness index was used, FF infants 
had significantly higher richness than BF infants at six weeks (Chao1: p = 0.0085; Fig. 2b) and 12 weeks (Chao1: 
p = 0.0005; Fig. 2f) of age, and when age groups were combined (Chao1: p = 0.0002; Fig. 2h). The fact that differ-
ences in bacterial richness and diversity were only observed with Chao1 and Shannon indices but not with PD 
Whole Tree index suggests that those differences mostly concerned closely related taxa. The Shannon’s diversity 
index accounts for both abundance and evenness of the species present, whereas the PD Whole Tree index meas-
ures phylogenetically weighted species richness.
In the KOALA study cohort there was a statistically significant difference in diversity estimated with the 
Shannon Diversity Index between BF and FF infants (Shannon Diversity: p < 0.0001) and between FF and MF 
infants (Shannon Diversity: p = 0.035), but not between BF and MF infants (Fig. 2c), with the highest diversity 
detected in the FF infants. Comparison of alpha diversity based on the PD Whole Tree estimates showed no 
significant differences between infants receiving different feeding types (data not shown). Bacterial richness was 
significantly higher in the FF infants as compared to BF infants (Chao1: p < 0.0001; Fig. 2d). In general, both the 
faecal bacterial diversity and richness were higher in FF infants as compared to BF infants, whereas MF infants 
showed an intermediate phenotype.
In both BINGO and KOALA sample sets, Principle Component Analysis (PCA) revealed grouping of samples 
into FF and BF groups with the MF samples scattered in between (Fig. 3a,b). There was no separation of samples 
from the 17 FF infants in the KOALA cohort who received prebiotic fortified formula (p = 0.076). The separation of 
samples according to the feeding mode was more pronounced among the KOALA cohort infants, and the bacterial 
taxa driving the separation differed between the studies. Nevertheless, despite a much smaller FF group size in the 
BINGO cohort, the overall sample distribution pattern on the PCA plots was conserved between both studies.
Figure 1. Average relative abundance of genus level taxa in faeces of infants included in the BINGO and 
KOALA cohorts that were either breastfed (BF), formula fed (FF) or fed both breastmilk and formula 
(mixed fed, MF). When the taxonomic assignment could not be made at genus level, the lowest classifiable 
taxonomy assignment is used instead and unidentified genus is indicated with “g_g”. Taxa that significantly 
differ (Wilcoxon test, FDR < 0.05) in their relative abundance between BF and FF infants are indicated with 
*(BINGO) and #(KOALA).
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Redundancy analysis (RDA) was used to assess the amount of variation in the microbial composition data, 
which could be explained by feeding mode and additional demographic factors recorded for the two different 
cohorts. These factors included place and mode of delivery, gender, and medication use (Fig. S2a,b). The inter-
active forward selection method identifies a subset of variables that best explain the variation in the data. In the 
BINGO cohort, when all samples were analysed together, age, feeding (BF, FF, MF), mode of delivery (C-Section, 
vaginal), place of delivery (home, hospital, clinic), and medication had a significant effect on microbiota compo-
sition (FDR < 0.05) and together explained 13.7% of variation. In the KOALA cohort, feeding and delivery mode 
were selected (FDR < 0.05) during interactive forward selection, and they together explained 9.5% variation. 
To investigate the residual effect of feeding mode separately, we repeated the RDA analysis with feeding mode 
as the main factor and all other factors selected during the interactive selection process as covariates. In both 
Figure 2. Alpha diversity of faecal microbiota in breastfed (BF), formula fed (FF) or mixed fed (MF) infant 
groups; (a) Bacterial diversity in the BINGO study infants at six weeks of age; (b) Bacterial richness in the 
BINGO study infants at six weeks of age; (c) bacterial diversity in the KOALA study infants at one month of age; 
(d) Bacterial richness in the KOALA study infants at one month of age; (e) Bacterial diversity in the BINGO 
study infants at 12 weeks of age; (f) Bacterial richness in the BINGO study infants at 12 weeks of age;  
(g) Bacterial diversity in the BINGO study infants at two, six, and 12 weeks of age combined; (h) Bacterial 
richness in the BINGO study infants at two, six, and 12 weeks of age combined. *Indicates statistically 
significant difference between groups (p < 0.05).
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the BINGO cohort and in the KOALA cohort, the effect of feeding was significant (FDR < 0.05), and feeding 
explained 2.9%, and 6.2% of the residual variation, respectively (Fig. 4a,b).
We then applied the same approach at each time point separately to investigate in more detail the effect of 
different factors (feeding, place and mode of delivery, gender, and medication use) in the BINGO cohort data 
(Fig. 5). The interactive selection showed that both the place and the mode of delivery had a significant effect 
on microbiota at two weeks of age (FDR < 0.05). At six weeks, the effects of mode of delivery and feeding were 
significant, and at 12 weeks only the effect of feeding was significant. When delivery mode was set as covariate, 
feeding could explain 4.5% of the residual variation in the microbiota composition at week six and increased to 
5.9% at week 12.
In both studies, RDA analyses showed that breastfeeding and formula feeding resulted in differences in micro-
biota composition (FDR < 0.05). In contrast, the effect of mixed feeding was not significant in the KOALA cohort 
and in the six week old infants in the BINGO cohort. However, when samples from all time points in the BINGO 
cohort were analysed together, we saw a significant difference between infants receiving MF and the other two 
feeding groups.
We observed a large variation in microbiota composition between individual infants in both studies, inde-
pendent of feeding or delivery mode. We used Dirichlet Multinomial Mixtures (DMM) modelling22 to assign 
samples into three clusters based on the relative abundance of the microbial groups at genus level of classification 
(Fig. 6a). The clustering was performed independently for both studies. There were some minor differences in 
the average relative contribution of individual taxa between the clusters A, B and C, from each sample sets, but 
the overall pattern within each cluster type was preserved (Fig. S3). Cluster A contained samples with mixed 
microbial composition, low relative abundance of Bifidobacterium and relatively high proportion of Streptococcus 
and other microbial groups. Cluster B showed high relative abundance of both Bifidobacterium and Bacteroides, 
whereas in cluster C Bifidobacterium was the dominating genus (Fig. 6a). The same cluster pattern was visible 
when samples were divided into subgroups based on the infants’ age or delivery mode (data not shown). Infant 
age and feeding mode were associated with cluster assignment of samples in the BINGO cohort. At two weeks 
of age, 50% of all samples from BF infants, 75% from FF and 57% of MF infants clustered in group A (Fig. 6b), 
but as the infants aged their faecal microbiota composition gradually became dominated by Bifidobacterium 
(clusters B and C). This gradual transition pattern was clear in BF infants, however, it was distorted in infants 
who received formula, either as a sole source of food or as supplementary feeding (Fig. 6b). In the subset of the 
individual infants (n = 60) from the BINGO cohort, where samples from all three time points were available, 
infants were more likely to stay within the same cluster between two and 12 weeks of age, and if they switched to 
a different cluster group the change was towards the Bacteroides/Bifidobacterium or Bifidobacterium rich clusters 
B and C (Fig. 6c). While all infants that received mixed feeding remained in cluster A, all infants who changed 
from breastfeeding to formula also switched from clusters A or B into cluster C. In the KOALA cohort, cluster 
assignment of BF infants showed a similar result to that of the BINGO cohort at six weeks. However, an opposite 
trend was found for FF and MF infants, where over 90% of infants could be categorized within clusters A or B, 
showing low to moderate relative abundance of faecal Bifidobacterium.
Clustering of the 186 samples from the BINGO cohort corresponding to the 66 vaginally delivered infants led 
to the same cluster structure. Similar results were obtained when clustering was restricted to the 211 vaginally 
delivered infants from the KOALA cohort. Restriction of the analysis to the samples from C-section born infants 
led to no reliable clusters due to the low number of samples (n = 20 in BINGO, n = 28 in KOALA). Cluster assign-
ments of samples grouped for other characteristics (delivery place, infant sex or weight at birth) were inspected 
and compared with overall study distribution, but no significant associations were found (p > 0.05).
Figure 3. PCA analysis of log transformed genus level relative abundance data. Samples coloured by infant 
feeding type showing separation between different feeding modes. Microbial groups that significantly differ in 
relative abundance (Wilcoxon test, FDR < 0.05) between BF and FF groups are displayed; (a) BINGO study, (b) 
KOALA study.
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In order to examine the effect of the time gap between the KOALA and BINGO cohorts, and the differences in 
infant ages and DNA extraction protocols, we compared microbiota profiles of two subsets of samples obtained 
from vaginally delivered, healthy BF infants at six weeks (BINGO cohort: n = 51, girls/boys ratio = 23/28, 
mean age = 6.1, median age = 6.1, SD = 0.20) and at four to six weeks old (KOALA cohort: (n = 97, girls/boys 
ratio = 48/49, mean age = 4.5 wk, median age = 4 wk, SD = 0.59). RDA analysis revealed that when infant age 
and gender were treated as covariates, the cohort time could explain 1.24% of residual variation in the micro-
biota (FDR = 0.01). In the BINGO cohort there was a higher relative abundance of Actinomyces, Streptococcus, 
Enterococcus, Bifidobacterium, Peptostreptococcaceae g_Incertae_Sedis, and unidentified genera within families 
Enterobacteriaceae and Actinomycetaceae (FDR < 0.05), whereas in the KOALA cohort there was a higher rela-
tive abundance of Lactococcus, Leuconostoc, Clostridium and unidentified genus within family Streptococcaceae 
(Kruskal-Wallis analysis).
Discussion
The current study examined faecal microbiota composition in healthy infants sampled at two, six and 12 weeks 
of age from the BINGO study cohort (year 2015–2016) and infants sampled at approximately one month of 
age from the KOALA study cohort (year 2002–2003). All infants received either commercially available formu-
las, breastmilk or mixed feeding. At the time samples from the KOALA cohort were collected, infant formulas 
enriched with prebiotics were available on the Dutch market only to a limited extent. It is important to note that 
a number of other factors such as lifestyle, maternal diet, infant age, delivery and rearing practices, climate, and 
many other environmental factors have changed between the time the samples from the KOALA and BINGO 
cohorts were collected. These factors might also have influenced the composition of infant microbiota, in addition 
to the effects due to different feeding modes. In fact, we could detect difference in the microbiota of the vaginally 
delivered, exclusively BF infants of similar ages from the two study cohorts. Thus, to reduce bias associated with 
using data from two different study cohorts we focused our analyses on the within-cohort comparisons. Using 
this approach, we showed that faecal microbiota composition of infants fed modern types of formulas containing 
prebiotics was more similar to faecal microbiota of BF infants. This trend was not observed in FF infants receiving 
Figure 4. Partial RDA analysis with covariates, using the log transformed genus level relative abundances. 
Samples coloured by infant feeding type (BF, breastfeeding; FF, formula feeding; MF, mixed feeding) showing 
separation between different feeding modes. Microbial groups that significantly differ in relative abundance 
(Wilcoxon test, FDR < 0.05) between BF and FF groups are displayed; (a) BINGO study, (b) KOALA study.
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unsupplemented formulas available in years 2002–2003. The bifidogenic effect of prebiotic fortified formulas was 
not observed in MF infants.
The majority of infant formulas available on the Dutch market nowadays are supplemented with GOS and/
or FOS, but new innovations are appearing, such as chicory oligofructose(FOS):lcFOS mixes used in hypoal-
lergic infant formulas. Previous studies showed that the mixture of GOS and/or FOS stimulated growth of 
Bifidobacterium in preterm23–25 and term infants26–28, and that GOS/FOS supplementation also resulted in a met-
abolic activity of the colonic microbiota, as measured by SCFA and faecal pH, that was similar to the metabolic 
activity in BF controls26,28. However, many of the microbiological data in these earlier studies were obtained using 
traditional culture- or molecular probe-based methods, which were often limited in their accuracy or the scope 
of microbial detection29. Here, we have compared samples from two study cohorts obtained more than ten years 
apart. The use of next generation sequencing in our study allowed us to gain a more comprehensive insight into 
microbial composition and dynamic patterns at a microbial community level.
In both studies unconstrained multivariate analysis revealed a clear separation of samples relating to the feed-
ing mode (Fig. 3). This is in agreement with a number of earlier studies which showed distinctively different faecal 
microbial profiles when comparing BF, FF and MF infants29–31. We found that in both study cohorts feeding mode 
Figure 5. RDA analysis with covariates, using the log transformed genus level relative abundance data at each 
time point in the BINGO cohort. Samples coloured by infant feeding type (BF, breastfeeding; FF, formula 
feeding; MF, mixed feeding) showing separation between different feeding modes. Microbial groups that 
significantly differ in relative abundance (Wilcoxon test, FDR p < 0.05) between BF and FF groups at each time 
point are displayed.
BF             FF              MF
n=121        n=103        n=15
BF                               FF                                   MF
n=156                           n=25                               n=23 
BINGO (n=204)                                                           KOALA (n=239) 
n=52  n=54  n=50          n=4   n=8  n=13            n=7   n=6   n=10 
a. b.
c.
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MF
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v
Week 2
Week 6 
Week 12
A
B
C
Cluster A
Cluster B
Cluster C
2    6    12           2     6    12          2     6    12           4            4            4
Age (Weeks)g_Bifidobacterium          g_Streptococcus
g_Bacteroides                 Other 
Cluster A
Cluster B
Cluster C
Figure 6. DMM clustering of samples on the basis of faecal microbiota composition at genus level; (a) Average 
relative abundance of microbial groups characteristic to individual cluster A, B and C; (b) Fraction of samples 
from infants receiving different types of feeding (BF, breastfeeding; FF, formula feeding; MF, mixed feeding) 
within each cluster category; (c) Temporal evolution of cluster assignment for infants in the BINGO study 
cohort, indicating cluster type (red - cluster A, green - cluster B, blue - cluster C), and type of feeding at each 
time point (square - BF, circle - MF, triangle - FF).
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was associated with faecal microbiota composition (Fig. 4), and that bacterial diversity and richness in BF infants 
was significantly lower than in FF infants, except for the six week old infants from the BINGO cohort for which 
no difference in diversity was observed (Fig. 2). Diversity evaluates both the number of species and the evenness 
of their distribution. Earlier studies showed that formula feeding was associated with higher faecal microbial 
diversity, and more adult like microbiota composition31,32 and microbiota activity33. Recently, higher microbial 
diversity at four months of age (“premature maturation”) has been associated with an increased risk for develop-
ing Celiac Disease later in life34. The authors concluded that colonisation dynamics with gradual establishment 
of complex microbial communities might be important in development of immune tolerance and thus, reduced 
disease risk. In contrast, higher microbial diversity and high abundance of butyrate producing bacteria in infants 
around weaning age (6–9 mo.) was associated with alleviating symptoms of atopic eczema, which also supports 
the idea that the timing in microbiota development might play an important role in immune programming35. 
In the BINGO cohort, FF infants showed an overall higher number of genus level taxa in their faeces in all age 
groups as estimated by the Chao1 index. This difference was most prominent at six weeks (31.5, SD = 8.8 in FF 
and 22.5 SD = 6.5 in BF; Fig. 2b). Yet, the evenness, or relative contribution of each bacterial group, was similar 
between BF and FF in the BINGO cohort (Fig. 1), possibly due to more comparable relative abundance of the 
main groups in response to prebiotics36. Despite the similarities, the relative abundance of 12 genus level groups 
differed significantly between BF and FF infants in the BINGO study cohort. It should be noted, however, that the 
differences were mainly in the low abundance taxa which accounted for a very small fraction of the total bacteria 
in the community (Fig. 1). In contrast, in the KOALA cohort 19 genus level taxa varied significantly, and the dif-
ferences in both the species diversity and species richness were significant between FF and BF groups (Fig. 2c,d). 
Together these differentially abundant taxa in the KOALA cohort accounted for more than 60% of the total bac-
teria in the faeces of either BF or FF infants.
Despite the differences in the type of formula used, in both the BINGO and the KOALA cohorts FF was 
associated with a significant increase in relative abundance of Akkermansia, Enterococcus, Peptostreptococcaceae 
Incertae Sedis and Erysipelotrichaceae Incertae Sedis. Higher levels of these microbial groups in FF infants have 
been reported previously7,31,37. Interestingly, a similar effect was observed in piglets that were fed dairy milk-based 
formula and showed significantly higher levels of both Akkermansia and Enterococcus, indicating a possible effect 
of dairy milk compounds that are present in infant formulas38.
Our results showed few important differences in the faecal microbial composition between the BINGO and 
the KOALA cohorts. Clostridium and Escherichia-Shigella, both of which include important pathogens, showed 
higher relative abundance in the FF infants from the KOALA cohort, but not in the BINGO cohort, when com-
pared to the levels found in the corresponding BF groups. Another important difference pertains central bacterial 
groups, such as Bifidobacterium and Lactobacillus, whose relative abundance was reduced in the FF group from 
the KOALA cohort, but not in the BINGO cohort, as compared to BF infants from their corresponding cohorts. 
These results are in line with earlier findings on the microbiota composition changes due to prebiotic fortifica-
tion used in formulas36. Earlier culture-dependent studies based on colony counts and molecular based methods 
reported that GOS/FOS stimulated growth of bifidobacteria23 and lactobacilli, and led to reduction of Escherichia 
coli, Clostridium species and other clinically relevant pathogens39. We showed that prebiotic supplementation 
resulted in an increase in relative abundance of specific microbial species (or strains) of Bifidobacterium OTU 
L2 which was also the most predominant bifidobacterial OTU detected in the healthy BF infants (Fig. S1). Based 
on these findings we can conclude that the formulas used by the participants of the BINGO cohort appear to be 
better in mimicking the beneficial properties of human milk with respect to the stimulation of GI tract micro-
biota that is similar to that found in healthy BF infants (Fig. 1). In contrast to the earlier described intervention 
studies19,40, these differences have now been shown by comparing data from two population-based studies. In 
addition, studies on bifidobacteria and lactobacilli reported that prebiotic formulas and breastmilk may stimulate 
the same bacterial groups, but as it was shown for Lactobacillus, they may stimulate different species within the 
same group41,42. Thus, to further support our findings an approach allowing species or strains level identification 
might be necessary.
One of the main characteristics of the early life GI tract microbial ecosystems are low diversity and low sta-
bility32,43,44. These characteristics make the microbial ecosystems more vulnerable to environmental disturbance, 
and may explain the inconsistent patterns of distribution of taxa and high levels of inter-individual variability 
observed here and in other studies32,40. In our study we observed large differences between infants and to disclose 
any possible more generic patterns in the faecal microbial composition, we applied DMM clustering analysis to all 
samples from the BINGO and KOALA sets separately. These analyses revealed presence of three distinct clusters 
with very similar characteristics for the different cohorts (Fig. 6a). Furthermore, these clusters were still present 
when samples from only vaginally delivered BF infants were used in the modelling. In addition, these clusters 
were not associated with other characteristics such as sex, birth weight or place of delivery. This implies that other 
environmental or genetic factors might be driving development of specific microbial assemblages in the infant 
GI tract44, especially that the majority of factors which shape the human gut microbiota still remain unknown45. 
One such factor might be the composition of breastmilk from the individual mother-infant pairs. Earlier studies 
showed that the composition of breastmilk varies between individual mothers and across lactation stage with 
regard to human milk oligosaccharide (HMO) content and composition46, milk microbiota and other breastmilk 
factors which could influence GI colonisation47.
The large inter-individual variation in faecal microbial composition of infants has been noted before in a 
number of studies, but none of them indicated existence of enterotypes in infants2,5,48. Only recently, it has been 
suggested that three compositionally distinct human neonatal gut microbiota (NGM) profiles might be pres-
ent48,49 and linked to development of atopy in young infants48. However, whether the specific microbial patterns 
observed in early life are universal, whether they can prompt an individual to develop a given adult enterotype, 
or if they predispose an infant to any health conditions, remains to be investigated in future longitudinal studies.
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The longitudinal design of the BINGO study allowed us to examine the temporal pattern in the development 
of microbiota in infants from two to 12 weeks of age. Earlier studies indicated that the pattern of microbiota 
development is non-random3,50 and is correlated with the ability of an infant to effectively digest breastmilk 
HMOs, as the proportion of HMO consuming Bifidobacterium and Bacteroides increase51. We were interested in 
the relationship between each of the aforementioned clusters, infant age and feeding mode (Fig. 6b). In the BF 
group there was a clear directional trend, where faecal microbiota gradually transitioned from the “mixed” clus-
ter A to the Bifidobacterium dominated clusters B and C as infants got older. This pattern was different in infants 
receiving prebiotic formula, where exclusive formula feeding, or a change from breastfeeding to formula were 
associated with an accelerated shift in microbial community composition to cluster C, already at six weeks of age. 
This suggests that the establishment of a Bifidobacterium dominated ecosystem might be linked with the age of 
an infant or with breastmilk properties, whereas in the FF infants this maturation of the GI tract microbiota was 
shaped and accelerated by the prebiotic(s) included in the formulas, although this observation should be con-
firmed using larger sample sizes in the FF group at each time point. In contrast, the mixed feeding was associated 
with delayed microbiota development, with more infants at 12 weeks of age falling into the mixed microbiota 
cluster A, as compared to infants from the BF group (Fig. 6b). This mixed state was also characteristic to FF and 
MF infants receiving formulas with no prebiotics in the KOALA study. The clinical consequences of the timing 
of colonization with e.g. Bifidobacterium are still largely unknown, but a few studies up to date have implied that 
colonisation dynamics might affect immune programing and the health outcomes later in life34,40. The complex 
and dynamic structure of the human milk could be an important driving force shaping the GI microbiota in BF 
infants, and possibly play a role in the formation of the cluster groups observed in our data. Given that the amount 
of HMO’s in maternal milk changes over the first months of life, a way of avoiding the possibly unfavourable 
acceleration in microbial colonization related to FF would be to design formulas which would mimic the natural 
changes in HMO’s by varying the amounts of prebiotics for infants of different ages.
Finally, our findings suggest that the use of new formulas in combination with breastmilk feeding was asso-
ciated with more mixed microbiota composition and showed lower bifidogenic effect, thus implying a possible 
interference between the components of breastmilk and formula. A similar shift towards FF microbiota pattern 
in infants receiving MF has been noted in the past52. Unfortunately, in both cohorts the MF groups were small (23 
BINGO samples, 15 KOALA samples), preventing us from drawing strong conclusions. However, this mode of 
feeding represents a highly realistic scenario in today’s infant nutrition and thus, should be further investigated 
using a larger study cohort. Such a study would require a detailed knowledge of breastmilk composition, as well 
as information on the types of formulas that the infants received to enable detailed assessment of the effect of each 
component.
Materials and Methods
Formula and prebiotics. All formula fed (FF) infants received commercially available formulas purchased 
in the Netherlands between 2015–2016 (BINGO cohort), and between 2002–2003 (KOALA cohort). The preb-
iotic fortified infant formulas used in BINGO cohort typically contain scGOS (0.24–0.50 g/100 ml), or mixtures 
scGOS:lcFOS (9:1); 0.6 g/100 ml18,53. In the KOALA cohort 17 of 103 FF infants were confirmed to receive formu-
las containing scGOS or scGOS:lcFOS, while the remaining infants were fed traditional formulas with no added 
prebiotics.
Study description. The analyses described here are part of the BINGO and KOALA birth cohort studies. All 
infants included in this analysis were born at term (after 37 weeks of gestation), healthy, from singleton pregnan-
cies, had no congenital abnormalities related to growth, and none of the infants received oral or systemic antibi-
otic treatment during the study period. The BINGO (Dutch acronym for Biological Influences on Baby’s Health 
and Development) cohort is an ongoing longitudinal study investigating prenatal predictors of infant health and 
development. This study was approved by and carried in accordance to the ethical committee of the Faculty of 
Social Sciences of the Radboud University [ECSW2014-1003-189]. Expectant mothers in the BINGO cohort 
signed up via the project’s website, or folders that were handed out in midwife practices, pregnancy courses, and 
baby stores in the region Arnhem-Nijmegen (the Netherlands). Exclusion criteria were maternal drug use, regu-
lar alcohol consumption, and insufficient knowledge of the Dutch language. Infant faecal samples were collected 
between years 2015–2016, from a diaper by the mothers within a period of 48 h, when infants were two, six and 12 
week old using a sterile stool vial (80 × 16.5 mm; cat#:80.623.022; Sarstedt; Nümbrech, Germany). The mothers 
were asked to immediately store the samples in their home freezers (i.e., fresh frozen collection) until collected by 
the researcher. After collection, samples were stored at −80 oC until further processing and analysis.
The design, selection criteria and faeces collection procedure of the KOALA Birth Cohort Study (Dutch acro-
nym for: Child, Parents and Health: Lifestyle and Genetic Constitution) have been described elsewhere, and 
the study was approved by and carried in accordance with the Ethics Committee of the University Hospital of 
Maastricht54,55. In brief, the KOALA study included two recruitment groups of healthy pregnant women in the 
South of the Netherlands. The first group (n = 2343) was characterised by a conventional lifestyle, whereas fami-
lies included in the second group (n = 491) were considered to have an alternative lifestyle that could involve die-
tary habits (vegetarian, organic), child-rearing practices and/or low use of antibiotics, and were recruited through 
alternative channels, such as posters in organic food shops, anthroposophic doctors and midwives. Infant faecal 
samples were collected between years 2002–2003, by the parents at approximately one month postpartum by 
removing a sample from a diaper into a sterile tube, refrigerated, and sent to the lab by post within one day after 
collection. Samples were stored at −80 oC in peptone glycerol solution (10 g/L peptone water in 20 v/v% glycerol) 
at 1 g of faeces in 9 mL of solution until further processing and analysis.
In both studies, parents were asked to sign an informed consent and complete a questionnaire including infor-
mation regarding infant’s diet (breastmilk only, formula only, or mixed feeding), and the type of infant formula 
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BINGO Total N = 204 samples (77 infants)
Feeding Breastfed (n = 156) Formula fed (n = 25) Mixed fed (n = 23)
  2 weeks 52 4 7
  6 weeks 54 8 6
  12 weeks 50 13 10
Delivery mode
  Vaginal: 139 23 19
  C-section: 14 2 4
  No record: 3 0 0
Gender
  Male: 84 8 14
  Female: 69 17 9
  No record: 3 0 0
Gestation (weeks) Mean ± SEM ± SD 39.78 ± 0.20 ± 1.59 39.82 ± 0.35 ± 1.30 39.58 ± 0.39 ± 1.64
Birth weight (g) Mean ± SEM ± SD 3556 ± 56.21 ± 439 3551 ± 107.52 ± 402 3562 ± 114.27 ± 485
Age at collection (d) Mean ± SEM ± SD
  2 weeks 2.10 ± 0.04 ± 0.25 2.07 ± 0.07 ± 0.14 2.08 ± 0.03 ± 0.08
  6 weeks 6.14 ± 0.03 ± 0.20 6.23 ± 0.17 ± 0.06 6.17 ± 0.07 ± 0.17
  12 weeks 12.30 ± 0.05 ± 0.36 12.05 ± 0.08 ± 0.28 12.09 ± 0.06 ± 0.19
Health at collection
  Sick*: 12 1 2
  Not Sick: 139 24 21
  Unknown: 5 0 0
Maternal age **n = 64 **n = 13 **n = 18
Mean ± SEM ± SD 32 ± 0.46 ± 3.7 30 ± 1.00 ± 3.6 32 ± 0.92 ± 3.92
Maternal antibiotics in last trimester yes (n = 3) none none
KOALA Total N = 239 samples (239 infants)
Feeding Breastfed (n = 121) Formula fed (n = 103) Mixed fed (n = 15)
Delivery mode
  Normal vaginal: 100 80 12
  Assisted vaginal: 11 4 1
  C-section: 10 16 2
  No record: 0 3 0
Delivery place
  Home: 72 36 2
  Hospital: 49 63 13
  No record: 0 4 0
Gender
  Male: 62 61 10
  Female: 59 42 5
Gestation (weeks)
  Mean ± SEM ± SD 40.24 ± 1.2 ± 1.2 39.85 ± 0.1 ± 1.3 39.91 ± 0.47 ± 1.8
Birth weight (g)
  Mean ± SEM ± SD 3651 ± 43.48 ± 476 3505 ± 44.05 ± 445 3543 ± 71.27 ± 257
Age at collection (d)
  Mean ± SEM ± SD 32.56 ± 0.5 ± 5.4 31.39 ± 0.49 ± 4.9 35.67 ± 1.3 ± 4.9
Health at collection
  Sick: 3 3 0
  Not Sick: 118 100 15
Maternal age **n = 110 **n = 98 **n = 15
Mean ± SEM ± SD 33 ± 0.32 ± 3.4 33 ± 0.43 ± 4.0 35 ± 0.95 ± 3.7
Maternal antibiotics during last month of pregnancy yes (n = 3) yes (n = 3) none
Table 1. Sample (BINGO), and infant (KOALA) characteristics (N = 443). *Include: common cold, cramps, 
thrush, reflux or diarrhoea as reported by parents at time of sample collection. **n Indicates the number of 
mothers for which the data was available.
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used. The number of samples from each study cohort and relevant information on infant characteristics and 
feeding mode are summarised in Table 1. In the KOALA cohort the information about feeding mode referred to 
the time from birth until sample collection, whereas in the BINGO cohort it referred to feeding mode during each 
time interval, i.e. from birth to the first time point, and between subsequent time points.
A total of 443 faecal samples were analysed: 204 samples from 77 infants from the BINGO cohort, and 239 
samples from the KOALA cohort infants (Table 1). In the BINGO cohort eight children were born via C-section 
and 66 children were born vaginally (185 faecal samples). The proportion of samples from C-section infants in 
each feeding mode group was 0.08 for breastfed (BF) and for FF infants, and 0.17 in the mixed fed (MF) group. 
In total 60 infants could be followed at all three time points. In the KOALA cohort 239 samples were analysed for 
microbiota composition from 239 infants at approximately one month of age (mean age of all infants = 31 days, 
SD = 5). Of all infants, 121 were BF, 103 were FF and 15 were MF. The proportion of samples from C-section 
infants (n = 28) in each feeding mode group was 0.08 in BF, 0.13 in FF, and 0.12 in MF.
DNA extraction, library preparation and sequencing. In the KOALA cohort, the total DNA was 
extracted from the stool samples as previously described8, using the double bead-beating procedure followed 
by QIAamp DNA stool mini kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. In the 
BINGO cohort, total DNA extraction was done using the double bead-beating procedure with 0.1−0.15 g of faecal 
sample and 350 µL STAR buffer as previously described56. The V4 region of 16 S ribosomal RNA (rRNA) gene was 
amplified in duplicate PCR reactions, each in a total volume of 50 µL and containing 5–20 ng (KOALA) or 20 ng 
(BINGO) of template DNA56 using uniquely barcoded primers 515F-n (5′-GTGCCAGCMGCCGCGGTAA-) and 
806R-n (5′-GGACTACHVGGGTWTCTAAT)56.
Data analysis. The 16S rRNA sequencing data was processed and analysed using the NG-Tax analysis pipe-
line21. In brief, libraries were filtered to contain only read pairs with perfectly matching barcodes that were sub-
sequently used to separate reads by sample. Operational taxonomic units (OTUs) were assigned using an open 
reference approach and SILVA_111_SSU 16S rRNA gene reference database57. Diversity analyses were carried out 
in QIIME on rarefied data with OTU cut-off of 250058,59, and multivariate analysis was done in Canoco560. PCA 
and RDA were performed using the log transformed genus level relative abundances data obtained from NG-Tax. 
RDA is a multivariate linear regression model where several response parameters can be related to a set of envi-
ronmental (explanatory) variables. Statistical significance was assessed in Canoco5 under the full model using 
the Monte Carlo permutation test with 499 random permutations. Alpha diversity indices (Shannon, Chao1, and 
PD Whole Tree) for each sample were calculated in QIIME using genus level (L6) data obtained with NG-Tax. 
Alpha diversity index group comparisons were done in GraphPad (GraphPad Prism version 5.00 for Windows, 
GraphPad Software, San Diego, CA, USA, www.graphpad.com). When values within a group used in the analysis 
did not pass the Shapiro-Wilk normality test, the Kruskal–Wallis analysis was used to compare diversity indexes. 
If the values were normally distributed in all groups, Two-Way ANOVA analysis was used for group comparison. 
Statistical differences in relative abundance of genus level taxa between three different age groups or feeding 
modes were assessed with the Kruskal–Wallis test using QIIME. For pairwise comparisons the Wilcoxon test was 
used when possible, otherwise the Kruskal–Wallis test was applied (QIIME). The proportion of false positives was 
controlled by accounting for the False Discovery Rate (FDR)61. The significance cut-off was set at p < 0.05, and 
when multiple test correction was applied, an FDR ≤ 0.05 was chosen as threshold. Clusters were identified based 
on genus level microbial abundance data using Dirichlet Multinomial Mixture (DMM) modelling as described 
previously22. The number of Dirichlet components was selected by inspection of the fit of the model to the count 
data for varying numbers of components (1 to 7). Goodness of fit was assessed using the Laplace and the Akaike 
information criteria. Finally, each sample was assigned to the component for which it had the largest fitted value. 
These analyses were performed in R (version 3.3.1) using the DirichletMultinomial R package62.
Data Availability
KOALA data sets cannot be made publicly available due to data confidentiality and the potential to identify in-
dividual study participants from the data. Data are available to the research community through the Dataverse 
repository (URL hdl:10411/CEGPGR) upon request. BINGO data sets currently cannot be made publicly avail-
able due to the data being part of an ongoing longitudinal study. Parts of the data are available to the research 
community for scientific collaborations upon request to Prof. Dr. C. de Weerth at: Radboud University, Depart-
ment of Developmental Psychology, Montessorilaan 3, 6525 HR Nijmegen, The Netherlands, e-mail: Carolina.
deWeerth@radboudumc.nl.
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